The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103892556 10389255 6 F 1996 20160803 20140818 20160808 EXP BR-ROCHE-1176655 ROCHE 80.40 YR F Y 85.00000 KG 20160809 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103892556 10389255 1 PS RIVOTRIL CLONAZEPAM 1 Unknown AT NIGHT RJ1750 17533 2 MG TABLET QD
103892556 10389255 2 I RIVOTRIL CLONAZEPAM 1 RJ1750 17533
103892556 10389255 3 I RIVOTRIL CLONAZEPAM 1 RJ1750 17533
103892556 10389255 4 I SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown IN FASTING U 0 200 MG TABLET QD
103892556 10389255 5 I SIMVASTATIN. SIMVASTATIN 1 Unknown AT NIGHT U 0 40 MG TABLET QD
103892556 10389255 6 SS CLONAZEPAM. CLONAZEPAM 1 Unknown 17533
103892556 10389255 7 SS CLONAZEPAM. CLONAZEPAM 1 17533

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103892556 10389255 1 Sleep disorder therapy
103892556 10389255 2 Pain
103892556 10389255 3 Anxiety
103892556 10389255 4 Thyroid disorder
103892556 10389255 5 Blood cholesterol abnormal
103892556 10389255 6 Insomnia
103892556 10389255 7 Pain

Outcome of event

Event ID CASEID OUTC COD
103892556 10389255 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
103892556 10389255 Abnormal behaviour
103892556 10389255 Blindness
103892556 10389255 Blood cholesterol abnormal
103892556 10389255 Breast cancer
103892556 10389255 Breast injury
103892556 10389255 Diabetes mellitus
103892556 10389255 Dizziness
103892556 10389255 Drug dose omission
103892556 10389255 Drug ineffective
103892556 10389255 Drug interaction
103892556 10389255 Dysgeusia
103892556 10389255 Dysstasia
103892556 10389255 Eye irritation
103892556 10389255 Eye pain
103892556 10389255 Fall
103892556 10389255 Glaucoma
103892556 10389255 Headache
103892556 10389255 Hypertension
103892556 10389255 Oral discomfort
103892556 10389255 Oral pain
103892556 10389255 Oropharyngeal pain
103892556 10389255 Retinal disorder
103892556 10389255 Stomatitis
103892556 10389255 Suicidal ideation
103892556 10389255 Thyroid disorder
103892556 10389255 Visual acuity reduced
103892556 10389255 Visual impairment
103892556 10389255 Wound

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103892556 10389255 1 1996 0